Aikang Diagnostics

Aikang Group is a national high-tech enterprise specialized in R&D, production, sales and service of medical devices. Founded in 2003, Aikang is headquartered in Shenzhen China and has established three R&D and production bases with a total area of ​​30,000 sqm and hundreds of employees: Aikang MedTech Co., Ltd. for medical automation solutions, Aikang Diagnostic Co., Ltd. for in-vitro diagnostic solutions and Aisikang MedTech Co., Ltd. for medical consumables.

Aikang is always focusing on innovation and quality, constantly communicating with partners from Germany, Switzerland etc., and insisting on developing products under international standards with its own intellectual properties. Every year, over 10% of sales revenue is invested in R&D. By 2020, Aikang has achieved 187 patents applied and certificates of ISO, CE etc.

Since the establishment of Aikang Diagnostic, below technology platforms have been developed: Chemiluminescence Immunoassay (CLIA), immunofluorescence chromatography, colloidal gold immunochromatography, blood grouping. With items covering diagnostic areas of cardiovascular diseases, inflammation, fertility, thyroid, infectious diseases, blood grouping etc., Aikang is dedicated to providing innovative solutions with good quality and professional service for hospitals and laboratories.